Endometrial carcinoma

Medical Radiology

Volumn 137, Issue , 2015, Pages 101-119

  Frei Bonel, Kathrin A ^a   Kinkel, Karen ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Institut de Radiologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ENDOMETRIAL CARCINOMA; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYMPTOM;

EID: 84922950163     PISSN: 09425373     EISSN: 21974187     Source Type: Book Series    
DOI: None     Document Type: Article

References (48)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366:491-505
2. Agboola OO, Grunfeld E, Coyle D, Perry GA (1997) Costs and benefi ts of routine follow-up after curative treatment for endometrial cancer. CMAJ 157:879-886
3. Arko D, Takac I (2000) High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. J Ultrasound Med 19:639-643
4. Bipat S, Glas AS, van d, V, Zwinderman AH, Bossuyt PM, Stoker J (2003) Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91:59-66
5. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17
6. Boronow RC, Morrow CP, Creasman WT, DiSaia PJ, Silverberg SG, Miller A, Blessing JA (1984) Surgical staging in endometrial cancer: clinical-pathologic fi ndings of a prospective study. Obstet Gynecol 63:825-832
7. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638
8. Clark TJ (2004) Outpatient hysteroscopy and ultrasonography in the management of endometrial disease. Curr Opin Obstet Gynecol 16:305-311
9. Clement PB, Young RH (2002) Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 9:145-184
10. Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94:256-266
11. Creasman WT (1990) New gynecologic cancer staging. Obstet Gynecol 75:287-288
12. Creasman WT (1995) New gynecologic cancer staging. Gynecol Oncol 58:157-158
13. Cunha TM, Felix A, Cabral I (2001) Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and gross visual inspection. Int J Gynecol Cancer 11:130-136
14. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R (1982) Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 50:163-170
15. Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850-855
16. Frei KA, Kinkel K, Bonel HM, Lu Y, Zaloudek C, Hricak H (2000) Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrastenhanced MR imaging-a meta-analysis and Bayesian analysis. Radiology 216:444-449
17. Grasel RP, Outwater EK, Siegelman ES, Capuzzi D, Parker L, Hussain SM (2000) Endometrial polyps: MR imaging features and distinction from endometrial carcinoma. Radiology 214:47-52
18. Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE (2001) Pap smears in women with endometrial carcinoma. Acta Cytol 45:555-560
19. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS (2002) Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 81:799-816
20. Harvey EB, Brinton LA (1985) Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112
21. Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Brix G, Essig M, Hoffmann U, Zuna I, Schonberg S, van Kaick G (1996) Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. Radiology 201:531-539
22. Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ, Chen VW (1996) Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 88:919-926
23. Hinkula M, Pukkala E, Kyyronen P, Kauppila A (2002) Grand multiparity and incidence of endometrial cancer: a population-based study in Finland. Int J Cancer 98:912-915
24. Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S (1997) A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 65:82-87
25. Hubacher D, Grimes DA (2002) Noncontraceptive health benefi ts of intrauterine devices: a systematic review. Obstet Gynecol Surv 57:120-128
26. Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531-43
27. Kinkel K (2005) Pitfalls in staging uterine neoplasm with imaging: a review. Abdominal Imaging 2005 Dec 5; [Epub ahead of print]
28. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, Hricak H (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212:711-718
29. Kjaer SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH (2004) Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol 33:596-602
30. Kucera H, Vavra N, Weghaupt K (1990) [Value of irradiation alone of generally inoperable endometrial cancer with high dose rate iridium 192] Zum Wert der alleinigen Bestrahlung des allgemein inoperablen Endometriumkarzinoms mittels High-Dose-Rate-Iridium-192. Geburtshilfe Frauenheilkd 50:610-613
31. Kucera E, Kainz C, Reinthaller A, Sliutz G, Leodolter S, Kucera H, Breitenecker G (2000) Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest 49:62-66
32. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK (1996) Prognostic signifi cance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394-398
33. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB (2004) Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health 94:2104-211
34. Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF, Giordano D, Scambia G, Marano P (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372-378
35. Murakami T, Kurachi H, Nakamura H, Tsuda K, Miyake A, Tomoda K, Hori S, Kozuka T (1995) Cervical invasion of endometrial carcinoma-evaluation by parasagittal MR imaging. Acta Radiol 36:248-253
36. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, Medl M, Rosen A, Wierrani F, Neunteufel W, Frech I, Preyer O, Speiser P, Kainz C (2000) Impact of hysteroscopy on disease-free survival in clinically stage I endometrial cancer patients. Int J Gynecol Cancer 10:275-279
37. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33-64, 1
38. Podratz KC, Mariani A, Webb MJ (1998) Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 70:163-164
39. Popovich MJ, Hricak H, Sugimura K, Stern JL (1993) The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 160:525-531
40. Santin AD, Bellone S, O›Brien TJ, Pecorelli S, Cannon MJ, Roman JJ (2004) Current treatment options for endometrial cancer. Expert Rev Anticancer Ther 4:679-689
41. Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P, DelMaschio A (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185:207-212
42. Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 280:1510-1517
43. Tabor A, Watt HC, Wald NJ (2002) Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 99:663-670
44. Takeuchi M, Matsuzaki K, Uehara H, Yoshida S, Nishitani H, Shimazu H (2005) Pathologies of the uterine endometrial cavity: usual and unusual manifestations and pitfalls on magnetic resonance imaging. Eur Radiol 15:2244-2255
45. Ulbright TM, Roth LM (1985) Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 16:28-34
46. Umar A, Risinger JI, Hawk ET, Barrett JC (2004) Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 4:153-158
47. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H (1993) Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 186:495-501
48. Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1995) The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defi ned nuclear grading system. A Gynecologic Oncology Group study. Cancer 75:81-86